446 related articles for article (PubMed ID: 17572410)
41. The GnRH agonists in the treatment of uterine leiomyomas.
Bianchi S; Fedele L
Acta Eur Fertil; 1989; 20(1):5-10. PubMed ID: 2675524
[TBL] [Abstract][Full Text] [Related]
42. The need for add-back with gonadotrophin-releasing hormone agonist therapy.
Studd J; Leather AT
Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():1-4. PubMed ID: 8916978
[TBL] [Abstract][Full Text] [Related]
43. Presurgical treatment of uterine fibroids by using gonadotropin-releasing hormone agonists.
Falsetti L; Mazzani MD; Rubessa S; Ruggeri C
Acta Eur Fertil; 1992; 23(1):29-32. PubMed ID: 1293897
[TBL] [Abstract][Full Text] [Related]
44. [The effects of menopausal replacement therapy in women with uterine myomas].
Orsini G; Pinto V; Di Biase S; D'Altorio C; Lanzilotti G
Minerva Ginecol; 1999 Nov; 51(11):421-5. PubMed ID: 10726441
[TBL] [Abstract][Full Text] [Related]
45. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
46. [Adjuvant therapy during the administration of GnRH agonists].
Nikolov A; Kolarov G
Akush Ginekol (Sofiia); 2002; 41(2):36-40. PubMed ID: 12066551
[No Abstract] [Full Text] [Related]
47. Long-term treatment of uterine fibroids with ulipristal acetate ☆.
Donnez J; Vázquez F; Tomaszewski J; Nouri K; Bouchard P; Fauser BC; Barlow DH; Palacios S; Donnez O; Bestel E; Osterloh I; Loumaye E;
Fertil Steril; 2014 Jun; 101(6):1565-73.e1-18. PubMed ID: 24630081
[TBL] [Abstract][Full Text] [Related]
48. Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III-IV. A randomized comparative trial.
Sesti F; Pietropolli A; Capozzolo T; Broccoli P; Pierangeli S; Bollea MR; Piccione E
Fertil Steril; 2007 Dec; 88(6):1541-7. PubMed ID: 17434511
[TBL] [Abstract][Full Text] [Related]
49. Ulipristal acetate versus placebo for fibroid treatment before surgery.
Donnez J; Tatarchuk TF; Bouchard P; Puscasiu L; Zakharenko NF; Ivanova T; Ugocsai G; Mara M; Jilla MP; Bestel E; Terrill P; Osterloh I; Loumaye E;
N Engl J Med; 2012 Feb; 366(5):409-20. PubMed ID: 22296075
[TBL] [Abstract][Full Text] [Related]
50. Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo.
Barlow DH; Lumsden MA; Fauser BC; Terrill P; Bestel E
Hum Reprod; 2014 Mar; 29(3):480-9. PubMed ID: 24457604
[TBL] [Abstract][Full Text] [Related]
51. Medical management of fibroids.
Sankaran S; Manyonda IT
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
[TBL] [Abstract][Full Text] [Related]
52. The secretion of insulin-like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonist.
Rein MS; Friedman AJ; Pandian MR; Heffner LJ
Obstet Gynecol; 1990 Sep; 76(3 Pt 1):388-94. PubMed ID: 2116610
[TBL] [Abstract][Full Text] [Related]
53. Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.
Kenemans P; Kubista E; Foidart JM; Yip CH; von Schoultz B; Sismondi P; Vassilopoulou-Sellin R; Beckmann MW; Bundred NJ; Egberts J; van Os S; Planellas J
Breast; 2007 Dec; 16 Suppl 2():S182-9. PubMed ID: 17983942
[TBL] [Abstract][Full Text] [Related]
54. Clinical efficacy of goserelin (Zoladex) in the treatment of uterine myomas in infertile patients.
Kopitović V; Bujas M; Fistes Topalski N; Pjević M; Ilić D; Kapamadzija A; Bujas I
Med Pregl; 2001; 54(7-8):339-46. PubMed ID: 11905182
[TBL] [Abstract][Full Text] [Related]
55. The effects of add-back therapy with tibolone on myoma uteri.
Göçmen A; Kara IH; Karaca M
Clin Exp Obstet Gynecol; 2002; 29(3):222-4. PubMed ID: 12519049
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the effects of tibolone and estrogen therapy on hemostasis in surgical menopause: a randomized, double-blind, placebo-controlled study.
Demirol A; Guven S; Guvendag Guven ES; Kirazli S; Gurgan T; Ayhan A
Fertil Steril; 2007 Apr; 87(4):842-8. PubMed ID: 17222829
[TBL] [Abstract][Full Text] [Related]
57. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
De Falco M; Staibano S; D'Armiento FP; Mascolo M; Salvatore G; Busiello A; Carbone IF; Pollio F; Di Lieto A
J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
[TBL] [Abstract][Full Text] [Related]
58. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy.
Murray SC; Muse KN
Fertil Steril; 1997 Feb; 67(2):390-3. PubMed ID: 9022620
[TBL] [Abstract][Full Text] [Related]
59. [Treatment of uterine fibroma with goserelin].
Alfini P; Bianco V; Felice R; Magro B
Ann Ostet Ginecol Med Perinat; 1991; 112(6):359-67. PubMed ID: 1842164
[TBL] [Abstract][Full Text] [Related]
60. Fibroids (uterine myomatosis, leiomyomas).
Lethaby A; Vollenhoven B
Clin Evid; 2004 Dec; (12):2563-85. PubMed ID: 15865807
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
